IP Library Granted Patent US 7,195,777
Granted Patent B2
US 7,195,777 · App. 10/220,491 · Granted Mar 27, 2007

Method and apparatus for blowmoding capsules of polyvinylalcohol and blowmolded polyvinylalcohol capsules

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,195,777
App. No.
10/220,491
Granted
Mar 27, 2007
Kind
B2
Abstract

A capsule is formed from a PVA composition by blow moulding. Such capsules can at last provide a viable alternative to gelatin for bio-degradeable capsule containing a pharmaceutical or consumable or other substance, for example a detergent. The capsules may contain solid or liquid substances. Blow moulding apparatus suitable for forming such capsules is also disclosed and claimed.

Claims (10)

1. An injection blow-moulded capsule having walls formed from a polyvinyl alcohol (PVA) containing composition, the walls enveloping a consumable substance, wherein the PVA composition consists essentially of 40%–80% by weight partially hydrolyzed PVA, 5 to 15% by weight of a plasticizer, 0.5% to 2.5% by weight a straight or branched chain C 12 to C 24 fatty acid amide as a lubricant and 5 to 50% of an inert or consumable filler comprising calcium carbonate.

2. A capsule according to claim 1 wherein the PVA comprises partially hydrolysed PVA having a molecular weight of at least about 10,000.

3. A capsule according to claim 1 wherein the plasticizer comprises glycerol.

4. A capsule according to claim 1 wherein the fatty acid amide comprises a C 16 to C 20 fatty acid amide.

5. A capsule according to claim 4 wherein the fatty acid amide comprises stearamide.

6. A capsule having walls formed from a polyvinyl alcohol (PVA) containing composition and containing a consumable substance, wherein the PVA composition consists essentially of 40–80% by weight partially hydrolyzed PVA, 5 to 10% by weight plasticizer, 0.5% to 2.5% of a straight or branched chain C 12 to C 24 fatty acid amide as a lubricant, 5 to 50% of an inert or consumable filler comprising calcium carbonate, and stearate as an external lubricant.

7. A capsule according to claim 1 wherein the capsule is sealed.

8. A capsule according to claim 1 wherein the substance is consumable and, wherein the PVA composition contains exclusively food grade ingredients.

9. A capsule according to claim 1 wherein the capsule has a volume of 5 cubic centimeters or less.

10. A capsule according to claim 1 wherein the capsule contains a measured dose of a pharmaceutical substance.

Assignments (3)
SECURITY AGREEMENT Recorded Oct 19, 2005
From: PVAXX RESEARCH AND DEVELOPMENT LIMITED; PVAXX IP LLC
To: MERRILL LYNCH PCG, INC.
Reel/Frame 016659/0370 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2005
From: PVAXX TECHNOLOGIES LIMITED
To: PVAXX RESEARCH AND DEVELOPMENT LIMITED
Reel/Frame 016416/0335 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2002
From: STEVENS, HENRY GUY; DAWSON, JOHN COLIN
To: PVAXX TECHNOLOGIES LTD.
Reel/Frame 013977/0332 →